99.2           Certification

Item 14.   Principal Accountant Fees and Services

Audit Fees. The Company incurred aggregate fees and expenses of $8,000
from David Winings C.P.A. for the fiscal year 2003 annual audit and for
review of the Company's quarterly financial statements included in its
Forms 10-QSB for the year 2003.

Tax Fees.   The Company did not incur any tax fees to David Winings,
C.P.A. for fiscal year 2003 and for professional services rendered for
tax compliance, tax advice, and tax planning.

                    SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, the Registrant caused this Registration Statement
to be signed on its behalf by the undersigned thereunto duly
authorized.

Dated: July 28, 2005

By:/s/ Dempsey K. Mork
          Dempsey K. Mork
          Chief Executive Officer/Director

Pursuant to the requirements of the Securities Exchange Act of 1934,
this report has been signed below by the following persons on behalf of
the Registrant and in the capacities indicated on July 28, 2005.

Dated:  July 28, 2005

By:/s/ Dempsey K. Mork
          Dempsey K. Mork
          Chief Executive Officer/Director

               CERTIFICATIONS

I, Dempsey K. Mork, certify that:

I have reviewed this annual report on Form 10KSB of Animal Cloning
Sciences, Inc.

Based on my knowledge, the annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, not misleading with respect to the period
covered by this annual report;
.. . .
<PAGE>22
Continuation of "Certification by Dempsey Mork, CEO/Director

Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly represent, in all
material aspects, the financial condition, results of operations and
cash flows of the registrant as of, and for, the periods presented in
this annual report;

The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
we have:

   designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;

   evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing date of
this annual report (the "Evaluation Date"); and,

   presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our
evaluation as of the Evaluation Date;

The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the
audit committee of the registrant's board of directors (or persons
performing the equivalent function):

   all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have
identified for the registrant's auditors any material weaknesses in
internal controls; and,

The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of most recent evaluation, including
any corrective actions with regard to significant deficiencies and
material weaknesses.

Date: July 28, 2005


/s/Dempsey K. Mork
- - ----------------------------
Dempsey K. Mork, President, Chief Executive Officer/Director

                    CERTIFICATIONS

I, Norbert LeBoeuf, certify that:
.. . .
<PAGE>23
I have reviewed this annual report on form 10KSB of Animal Cloning
Sciences, Inc.

Based on my knowledge, the annual report does not contain any untrue
statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which
such statements were made, no misleading with respect to the period
covered by this annual report;

Based on my knowledge, the financial statements, and other financial
information included in this annual report, fairly represent, in all
material aspects, the financial condition, results of operations and
cash flows of the registrant as of, and for the periods presented in
this annual report;

The registrant's other certifying officers and I are responsible for
establishing and maintaining disclosure controls and procedures (as
defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and
we have:

   designed such disclosure controls and procedures to ensure that
material information relating to the registrant, including its
consolidated subsidiaries, is made known to us by others within those
entities, particularly during the period in which this annual report is
being prepared;

   evaluated the effectiveness of the registrant's disclosure controls
and procedures as of a date within 90 days prior to the filing of this
annual report (the "Evaluation Date"); and,

   presented in this annual report our conclusions about the
effectiveness of the disclosure controls and procedures based on our
evaluation as of the Evaluation Date;

The registrant's other certifying officers and I have disclosed, based
on our most recent evaluation, to the registrant's auditors and the
audit committee of the registrant's board of directors (or persons
performing the equivalent function):

   all significant deficiencies in the design or operation of internal
controls which could adversely affect the registrant's ability to
record, process, summarize and report financial data and have
identifies for the registrant's auditors any material weaknesses in
internal controls; and,

The registrant's other certifying officers and I have indicated in this
annual report whether or not there were significant changes in internal
controls or in other factors that could significantly affect internal
controls subsequent to the date of most recent evaluation, including
any corrective actions with regard to significant deficiencies and
material weaknesses.
Date: July 28, 2005

/s/ Norbert L. LeBoeuf
-----------------------
Secretary & Chief Financial Officer
<PAGE>24